Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
OCS compared with AGMB: revenue, margins and what each company keeps, and the suppliers and customers both name
OCS
Oculis Holding AG
Change
Mkt cap
Revenue
Revenue
AGMB
Agomab Therapeutics NV
Change
Mkt cap
Revenue
Revenue
vs
Compare
OCS
Oculis Holding AG
vs
AGMB
Agomab Therapeutics NV
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
No disclosed counterparties: OCS, AGMB.
Role chip = supplier or customer
Source: SEC EDGAR
OCS
Oculis Holding AG
Change
7.74
▼
−6.26%
Mkt cap
$496.3M
AGMB
Agomab Therapeutics NV
Change
6.68
▼
−10.81%
Regular session
Nov 2 '26
Mkt cap
$255.9M
vs
Compare
Regular session
Nov 2 '26
OCS
Oculis Holding AG
vs
AGMB
Agomab Therapeutics NV
7.74
▼
−6.26%
Price
6.68
▼
−10.81%
$496.3M
Mkt cap
$255.9M
Change
Change
OCS
7.74
▼
−6.26%
vs
AGMB
6.68
▼
−10.81%
Regular session
Nov 2 '26